| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| C C Mermet, F G Gono. Ether stress stimulates noradrenaline release in the hypothalamic paraventricular nucleus. Neuroendocrinology. vol 47. issue 1. 1988-03-15. PMID:3340273. |
this effect appeared specific for noradrenergic terminals, since no effect on dopamine release was observed when recorded from the striatum or behind the paraventricular hypothalamic nucleus from the a13 dopaminergic group. |
1988-03-15 |
2023-08-11 |
rat |
| E Brenner, M Mirmiran, F Van Haaren, B C Theunisse, M G Feenstra, A A Lamur, C G Van Eden, J Van der Gugte. Central noradrenaline depletion during development and its effect on behaviour. Physiology & behavior. vol 41. issue 2. 1988-01-19. PMID:2825226. |
in the present study, 6-hydroxydopamine (6ohda) was injected into the lateral ventricles of 12 day old rats, permanently destroying most of the noradrenergic innervation of the spinal cord and of all the brain areas examined except for the pons/medulla, and reducing the dopamine content of the cerebral cortex considerably. |
1988-01-19 |
2023-08-11 |
rat |
| A R Crossman, C E Clarke, S Boyce, R G Robertson, M A Sambroo. MPTP-induced parkinsonism in the monkey: neurochemical pathology, complications of treatment and pathophysiological mechanisms. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. vol 14. issue 3 Suppl. 1988-01-13. PMID:3119180. |
it can also damage ventral tegmental dopamine neurones and the noradrenergic locus coeruleus, both of which may be affected in parkinson's disease. |
1988-01-13 |
2023-08-11 |
monkey |
| C Bel. Dopamine: precursor or neurotransmitter in sympathetically innervated tissues? Blood vessels. vol 24. issue 5. 1987-09-29. PMID:3304474. |
some of the unsolved questions relating to the neural release of dopamine are: is intravesicular dopamine in noradrenergic nerves a stable storage pool? |
1987-09-29 |
2023-08-11 |
Not clear |
| C Bel. Dopamine: precursor or neurotransmitter in sympathetically innervated tissues? Blood vessels. vol 24. issue 5. 1987-09-29. PMID:3304474. |
do noradrenergic nerves release dopamine and noradrenaline by identical mechanisms? |
1987-09-29 |
2023-08-11 |
Not clear |
| J F Plantjé, J Schipper, P F Verheijden, J C Stoo. D2-dopamine receptors regulate the release of [3H]dopamine in rat basal hypothalamus and neurointermediate lobe of the pituitary gland. Brain research. vol 413. issue 2. 1987-09-18. PMID:2955852. |
the release of [3h]dopamine was studied in these regions and desipramine was used to prevent uptake of [3h]dopamine in noradrenergic nerve terminals. |
1987-09-18 |
2023-08-11 |
rat |
| C Decavel, M Geffard, A Cala. Comparative study of dopamine- and noradrenaline-immunoreactive terminals in the paraventricular and supraoptic nuclei of the rat. Neuroscience letters. vol 77. issue 2. 1987-08-10. PMID:3601226. |
the distribution of dopaminergic and noradrenergic terminal fields of the paraventricular (pvn) and supraoptic (son) nuclei of the rat was investigated at the optic and electron microscopical level using antibodies directed against dopamine (da) and noradrenaline (na). |
1987-08-10 |
2023-08-11 |
rat |
| V A Russell, B Nurse, M C Lamm, J J Taljaar. Effect of chronic antidepressant treatment on noradrenergic modulation of [3H]dopamine release from rat nucleus accumbens and striatal slices. Brain research. vol 410. issue 1. 1987-07-14. PMID:3472627. |
effect of chronic antidepressant treatment on noradrenergic modulation of [3h]dopamine release from rat nucleus accumbens and striatal slices. |
1987-07-14 |
2023-08-11 |
rat |
| D J Heal, N Stoodley, J M Elliott, C A Marsden, G W Bennett, M B Youdi. Behavioural and biochemical evidence for the release of noradrenaline in mouse brain by TRH and some of its biologically stable analogues. Neuropharmacology. vol 26. issue 4. 1987-07-08. PMID:2884590. |
in addition, a comparison of the behavioural effects of trh compounds with dopamine and alpha 1-adrenoceptor agonists suggested that in mice these behavioural responses resulted from stimulation of both noradrenergic and dopaminergic function. |
1987-07-08 |
2023-08-11 |
mouse |
| A Härfstrand, P Eneroth, L Agnati, K Fux. Further studies on the effects of central administration of neuropeptide Y on neuroendocrine function in the male rat: relationship to hypothalamic catecholamines. Regulatory peptides. vol 17. issue 3. 1987-07-01. PMID:3589002. |
neuropeptide y seems to induce a biphasic change in amine utilization in the tuberoinfundibular dopamine (da) neurons and in the noradrenergic (na) utilization in various hypothalamic areas. |
1987-07-01 |
2023-08-11 |
rat |
| T Sunderland, P N Tariot, R M Cohen, P A Newhouse, A M Mellow, E A Mueller, D L Murph. Dose-dependent effects of deprenyl on CSF monoamine metabolites in patients with Alzheimer's disease. Psychopharmacology. vol 91. issue 3. 1987-05-20. PMID:2436247. |
these dose-dependent reductions are consistent with in vitro biochemical and anatomical data from primate brain suggesting that at low doses of deprenyl, mao-b inhibition might be expected to selectively affect dopamine and serotonin-containing neurons, while at higher doses (which lead to mao-a as well as mao-b inhibition), noradrenergic neurons may become relatively more affected by the drug. |
1987-05-20 |
2023-08-11 |
Not clear |
| J F Plantjé, H W Steinbusch, J Schipper, F A Dijcks, P F Verheijden, J C Stoo. D-2 dopamine-receptors regulate the release of [3H]dopamine in rat cortical regions showing dopamine immunoreactive fibers. Neuroscience. vol 20. issue 1. 1987-05-11. PMID:2951613. |
the release of [3h]dopamine from slices of all these cortical regions was studied in vitro in a superfusion system and desipramine was used to prevent the uptake of [3h]dopamine in noradrenergic nerve terminals. |
1987-05-11 |
2023-08-11 |
rat |
| B M Cohen, J F Lipinsk. In vivo potencies of antipsychotic drugs in blocking alpha 1 noradrenergic and dopamine D2 receptors: implications for drug mechanisms of action. Life sciences. vol 39. issue 26. 1987-02-11. PMID:2879204. |
in vivo potencies of antipsychotic drugs in blocking alpha 1 noradrenergic and dopamine d2 receptors: implications for drug mechanisms of action. |
1987-02-11 |
2023-08-11 |
rat |
| B M Cohen, J F Lipinsk. In vivo potencies of antipsychotic drugs in blocking alpha 1 noradrenergic and dopamine D2 receptors: implications for drug mechanisms of action. Life sciences. vol 39. issue 26. 1987-02-11. PMID:2879204. |
in addition to being dopamine antagonists, all antipsychotic drugs are potent antagonists of alpha-1 noradrenergic receptors. |
1987-02-11 |
2023-08-11 |
rat |
| B M Cohen, J F Lipinsk. In vivo potencies of antipsychotic drugs in blocking alpha 1 noradrenergic and dopamine D2 receptors: implications for drug mechanisms of action. Life sciences. vol 39. issue 26. 1987-02-11. PMID:2879204. |
after two drug-free days, rats were sacrificed and the affinity and density of dopamine d2 and alpha-1 noradrenergic receptors were determined in striatum and brain exclusive of striatum, respectively. |
1987-02-11 |
2023-08-11 |
rat |
| B M Cohen, J F Lipinsk. In vivo potencies of antipsychotic drugs in blocking alpha 1 noradrenergic and dopamine D2 receptors: implications for drug mechanisms of action. Life sciences. vol 39. issue 26. 1987-02-11. PMID:2879204. |
thus, preliminary experiments with this in vivo model suggest that all antipsychotic drugs are effective antagonists at alpha 1 noradrenergic receptors, while not all are effective antagonists at dopamine d2 receptors. |
1987-02-11 |
2023-08-11 |
rat |
| T Bradley, A Sollevi, M Lagerkranse. Effect of hypotension induced by sodium nitroprusside on catecholamine overflow in the canine kidney. Acta physiologica Scandinavica. vol 128. issue 2. 1986-12-05. PMID:3776649. |
the overflow of noradrenaline (na) and dopamine (da) to plasma in the kidney in response to hypotension induced by sodium nitroprusside were studied in barbiturate-anaesthetized dogs in order to evaluate the possible existence of separately regulated renal noradrenergic and dopaminergic nerve fibres. |
1986-12-05 |
2023-08-11 |
Not clear |
| P Soares-da-Silv. Evidence for a non-precursor dopamine pool in noradrenergic neurones of the dog mesenteric artery. Naunyn-Schmiedeberg's archives of pharmacology. vol 333. issue 3. 1986-10-30. PMID:3762736. |
evidence for a non-precursor dopamine pool in noradrenergic neurones of the dog mesenteric artery. |
1986-10-30 |
2023-08-11 |
dog |
| P Soares-da-Silv. Evidence for a non-precursor dopamine pool in noradrenergic neurones of the dog mesenteric artery. Naunyn-Schmiedeberg's archives of pharmacology. vol 333. issue 3. 1986-10-30. PMID:3762736. |
these results suggest the existence of a non-precursor dopamine pool in noradrenergic neurones supplying the proximal branches of the dog mesenteric artery, and also provide evidence in favour of the absence of independent dopaminergic neurones in this vascular area. |
1986-10-30 |
2023-08-11 |
dog |
| C D Anderson, R G Mair, P J Langlais, W J McEnte. Learning impairments after 6-OHDA treatment: a comparison with the effects of thiamine deficiency. Behavioural brain research. vol 21. issue 1. 1986-10-02. PMID:3091046. |
cortical norepinephrine, dopamine and 3,4-dihydroxyphenylacetic acid were reduced by injection of 6-hydroxydopamine (6-ohda) jointly into the cisterna magna and the dorsal noradrenergic bundle. |
1986-10-02 |
2023-08-11 |
Not clear |